Clearmind gets DSMB approval to test CMND-100 in AUD patients

Go back to Clearmind gets DSMB approval to test CMND-100 in AUD patients
(NASDAQ: CMND) Delayed: 1.03 --0 (-0%)
Previous Close $1.03    52 Week High
Open $1.03    52 Week Low
Day High $1.03    P/E N/A 
Day Low $1.03    EPS
Volume 42,494